We would love to hear your thoughts about our site and services, please take our survey here.
I would say so far the science has been good but the management of the company p@ss poor and no one has been held accountable .See how the SP reacts to ph1a results and if still poor call a EGM and get rid of one or two of the BOD . A shake up might be what we need to get interest into the company . What gets me is the constant demise of the SP considering what we have .On the question of buyouts what has the share price been before an off er was made to other companies because if this stays where it is a pound could be a good price
GLA
Maybe they should write our RNS was good to read an upbeat report and the only downside was this bit
The company's goal is clear: to initiate a Phase 1b clinical study by the end of 2024, pending satisfactory results and meeting regulatory requirements
Should have been as we all know complete the ph1b by 2024 unless time lines are slipping . We are not known to complete on time a downfall of SAR
GLA
Kool sentiment is probably most of us are still here and I’m sure I’ve heard the this is the perfect time to top up many times since the highs of 442 which as it stands we are 92pc down from that but would need to rise over 1200pc to get back there .Oppertunity yes agree but also think a lot have had enough and just willing to ride it out now .Good luck if you are buying at these prices
GLA
Silver exactly but there again news of the mtd could change things or will it be a pump and dump situation like the last 2 RNS .HNWI. Now would they consider jumping in again , possibly but if they did I’m sure they would want a day in how the company is being run .TM JR stay in the lab new chairman full time let’s hope so
GLA
How about we consolidate as no big pharma will be interested in a penny share company like us
Get a company like Peel Hunt who will open the doors for corporate investors
Finally if that fails look for the worst finance deal possible
Wait a minute
And we won’t have to tell the shareholders jack as they will all be happy with the present situation
GLA
Ps into the 20s next so save your money Laz as you don’t want to buy high now
Back to the 30s next week great news on the science not taken well by the markets the RF deal has well and truely shafted this share .Worth 50pc less than 10 years ago bad news get absolutely hammered good news a one day rise then drop
GLA
Good find HBD maybe you could send this to the BOD as they seem to know sweet FA or have any input into a molecule they helped to develop ,and unfortunately we seem to be heading to the 20s within a couple of weeks unless a miracle is pulled out .On completion of Ph1a do people see this rising or pumped and dumped as imho we have completed a trial but still no money coming in and would have to complete ph1b for data so any one interested could see the indications before jumping in . That would leave us open to total decimation of the SP and as mentioned open to a P@ss poor offer to a take over .If someone makes an offer no matter how low would the BOD have to let the shareholders know or could they turn it down until they think it is worth accepting
GLA
Https://www.morningstar.co.uk/uk/news/AN_1707825248833498700/in-brief-mgc-pharmaceuticals-proposes-name-change-to-argent-biopharma.aspx
Laz I’m in no doubt there are problems but also aware that if we have something which we all hope is as good as what TM and aJR are saying then we should not of had problems raising 5m
Look at the link above another of Parker’s failed consolidation plans no doubt and ask the shareholders over there what they think .Theres a point when we have to say enough is enough and do something about it .surely there must be someone else out there who would jump at the opportunity the head this ship just mho
GLA
From what I picked up at the AGM was the disbelief from one shareholder who challenged Parker about financing and he was in financing himself also the fact it wasn’t put our to raise from shareholders now this gentleman also explained about the lack of shares in Sar and how this was also restricting movement again the BOD and chairman always fleet over this question when asked even the investor meet when held .We had no say over 737 again and probably totally in the dark about possible time lines and yes I’ll mention 1802 to shame them again on lack of progress it’s a disgrace which has led us to becoming a single trick pony I know at least Parker reads the boards so have some balls and get some information out there even if it’s to say all is still going well
GLA
Potnak self harm how worse can it really get if good news is coming or bad we carnt change that but we can change the chairman if good news they will hopefully bring more than what has been brought so far and improve investor relations if bad they can then build agin instead of sitting on their hands doing sweet FA . As is showing this morning I believe a call for a EGM is not far away and if it came before new and Parker went it would be his own doing
GLA
Good point but again shows no forward thinking why stop at 3m when they know how much a trial costs again no work put in took the easy option ,apart from the abysmal SP everything good here hope your enjoying your retirement
GLA